Even after months of vaccinations, and nearly one million service members have received a vaccine, myths and misinformation surrounding the COVID-19 vaccines still abound.
However, the science behind the vaccines, and the effectiveness of those vaccines remain.
Some of the reasons why military personnel say they are not getting vaccinated include:
- Skepticism about the effects of the COVID-19 disease on young, healthy service members
- Questions about the vaccine’s possible long-term side effects that could emerge years later
- Changing information about the COVID-19 vaccines and the virus itself
- Concerns about a baby’s health in a pregnant service member
- Fears among male service members about their future fertility
Many of these concerns stem from false, inaccurate, or misleading information gathered from social media and misinformation super-spreaders.
Fact: The belief that young people cannot become seriously ill from catching the coronavirus is false. And newer, anecdotal reports suggest the virus’s Delta variant is causing more serious illness in young people compared to versions of the virus that were spreading last year.
The Truth About Side Effects
Fact: Even the young and healthy can still become infected and be a vector for spreading the virus, so everyone should get vaccinated to protect others, if not just themselves.
Fact: While there have been some rare but serious side effects detected after vaccinations – including an inflammation of the heart muscle and a neurological condition called Guillen-Barre syndrome, most of these cases recover. The Food and Drug Administration has months of data on the vaccines. That is from the more than 165 million people who are fully vaccinated in the U.S.
Fact: The messenger RNA vaccines from Pfizer-BioNTech and Moderna are based on a safe vaccine platform for which data go back to the 1990’s, and the Johnson & Johnson Janssen vaccine also is based on tried-and-true technology.
Fact: FDA is moving forward on full approval for COVID-19 vaccines, which may allay fears about long-term side effects. Pfizer submitted the vaccine for full approval July 16 for those ages 16 and older, according to the FDA. Moderna said it could apply for full approval before year-end.
On July 22, the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recommended that the Johnson & Johnson Janssen vaccine’s safety and effectiveness benefits still outweigh its rare risks for Guillen-Barre syndrome, and other side effects.
All three vaccines have rare adverse events including myocarditis/pericarditis, an inflammation of the heart. However, the ACIP decided that currently, the benefits still significantly outweigh the risks for COVID-19.